In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Heart failure with mid-range ejection fraction:the effects of short-term physical training

Session Poster Session 1

Speaker Dragan Marinkovic

Event : Heart Failure 2018

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure: Rehabilitation
  • Session type : Poster Session

Authors : D Marinkovic (Nis,RS), M Deljanin-Ilic (Nis,RS), V Stoickov (Nis,RS), B Ilic (Nis,RS), I Krstic (Nis,RS), S Stojanovic (Nis,RS), D Petrovic (Nis,RS)

D Marinkovic1 , M Deljanin-Ilic1 , V Stoickov1 , B Ilic1 , I Krstic1 , S Stojanovic1 , D Petrovic1 , 1University of Nis, Medical Faculty, Institute of Cardiology Niska Banja - Nis - Serbia ,


Heart failure with mid-range ejection fraction (HFmrEF), the „midlle child", as a new entity, in heart failure familly, has limited data regarding exercise tolerance and training, functional capacity and quality of life (QOL). Available data suggest that it constitutes a sizeable proportion(10–20%) of the HF population, has a unique clinical, echocardiographic, haemodynamic, and biomarker profile compared with HFrEF and HFpEF, and carries a poor prognosis.

Aim: To evaluate the effects of short-term physical training on physical exercise, tolerance and level of markers of inflammation, neuro-humoral activation and endothelial function, in patients wit HFmrEF.

Methods: The study involved 33 HF patients (21 males); mean age 60.3 ± 5.7 years, with established ischemic heart disease, mean EF 44,58 ± 5,23%, which fulfill criteria for HFmrEF. All patients were included in three-weeks rehabilitation program in the residential center, based on strictly controlled and individually prescribed physical training. Before and after rehabilitation, all patients were underwent exercise stress test, and from the veins blood samples, biochemical markers of inflammation, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) an endothelin (ET)  were determined.

Results: At the end of the study the hs-CRP and fibrinogen level were showed a decreasing trend (p=0.42; p=0.68 n.s). After cardiovascular rehabilitation a significant reduction in white blood cells count was recorded (p=0.022). Erythrocyte sedimentation rate after rehabilitation was higher, but not significant. In all pts, the concentration of ANP and BNP was lower after 3 weeks compared to baseline values (p=0.023; p=0.019). In contrast, the value of endothelin after rehabilitation was higher than baseline value (p=0.112), but not significant.  At end of this study, significantly higher serum HDL-cholesterol in CHF patients was found (p=0.001). Exercise tolerance after rehabilitation was improved (55.35 ± 5,23 W vs 74.69± 6.13 W; p=0.047), as well as quality of life assessed by Minnesota Living With Heart Failure Questionnaire (58,69± 3,69 vs 38,39± 2,24 p=0.035)

Conclusion: The results of our study showed that, in patients with the midrange LVEF residential short-term training has favourable impact expressed throught decreasing of  the level of inflammatory status and neuropeptids. Those positive effects are associated with significant increases of exercise tolerance and improvement of quality of life.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are